Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues.
Shin Hye YooJihui YunBhumsuk KeamSeung-Pyo HongChan-Young OckJaemoon KohSehui KimYoon Kyung JeonKyeong Cheon JungMiso KimTae Min KimDong-Wan KimJong-Il KimDae Seog HeoPublished in: Cancer immunology, immunotherapy : CII (2021)
Our study findings suggest that the observed increase in immunosuppressive markers after ICI might contribute to AR. Moreover, APOBEC-mediated PIK3CA mutagenesis might be an AR mechanism. To validate these mechanisms of AR, further studies with enough sample size are required.